October 8, 2020 Bio/Pharma/CRO Environ, Ag./Food & Bev Licensing, IP, and Legal

Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance to Deliver Integrated hiPSC Drug Discovery Solutions

MILAN (Italy) and MADISON (Wis., USA) –  October 6, 2020 – Axxam S.p.A., a leading provider of integrated drug discovery services across life sciences industries, and  FUJIFILM Cellular Dynamics, Inc., a leading developer and manufacturer of human induced pluripotent stem cell (hiPSC) models and therapies, announce a strategic alliance to improve the drug discovery process.... Read more

April 1, 2020 Environ, Ag./Food & Bev

FUJIFILM Irvine Scientific to Sell FUJIFILM Cellular Dynamics iCell Products

FUJIFILM Irvine Scientific creates the FUJIFILM “Discovery Research” organization to enable speedy, efficient delivery of FUJIFILM Cellular Dynamics iPSC-derived products through their worldwide distribution channels Madison, Wis./ Irvine, Calif., March 31, 2020— FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific iPSCs, and  FUJIFILM Irvine Scientific, Inc., a leader in cell culture media, announced that beginning April 1, 2020 iCell®... Read more

March 2, 2020 PAI Top-10 Product Launch

FUJIFILM Cellular Dynamics Begins Operations for Advanced Cell Therapies at its New Facility

FUJIFILM Cellular Dynamics Begins Operations for Advanced Cell Therapies at its New Facility – Fujifilm Cellular Dynamics Usage of Cookies: Cookies are important to the proper functioning of this site. To improve your experience, we use cookies to remember log-in details and provide secure log-in, collect statistics to optimize site functionality and deliver content tailored... Read more

December 5, 2019 Atomic Spectroscopy Clinical Research/Diagn. PAI Top-10

Fujifilm Establishes the Bio Science & Engineering Laboratories U.S.A. to Start Full-scale Translational Research for Biotherapeutics in the United States

Fujifilm Establishes the Bio Science & Engineering Laboratories U.S.A. to Start Full-scale Translational Research for Biotherapeutics in the United States – Fujifilm Cellular Dynamics Usage of Cookies: Cookies are important to the proper functioning of this site. To improve your experience, we use cookies to remember log-in details and provide secure log-in, collect statistics to... Read more

July 1, 2019 Clinical Research/Diagn. Licensing, IP, and Legal Product Launch

Century Therapeutics Launches with $250M Financing for iPSC Allogeneic Cell Therapy Platform

Tokyo, June 1, 2019 ― FUJIFILM Corporation (President: Kenji Sukeno) will accelerate the development of next-generation cancer immunotherapeutic drug candidates by harnessing the self-renewal potential of allogenic induced pluripotent stem cells (iPSCs). FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading developer and manufacturer of human iPSCs and tissue-specific cells differentiated from iPSCs, and Versant Venture Management,... Read more

January 8, 2019 Cell Analysis Tools Product Launch

FUJIFILM Cellular Dynamics Inc. Launches New Product iCell Microglia, an iPSC-Derived Neural Cell Type

hiPSC-derived microglia are utilized with the aim of advancing research to fulfill unmet medical needs for patients with neurodegenerative diseases MADISON, Wis., January 08, 2019 — FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and tissue-specific cells differentiated from iPSCs, has announced the launch of its... Read more

January 3, 2019 Cell Analysis Tools M&A, Partnerships

FUJIFILM Cellular Dynamics to Establish New Facility for Production of Human iPS Cell Therapy Applications

Fujifilm is investing in the cGMP-compliant facility located in Madison, Wisconsin with the goal to begin operations by March 2020 MADISON, Wis., January 3, 2019 — FUJIFILM Cellular Dynamics, Inc. (FCDI), a US subsidiary of FUJIFILM Corporation (President: Kenji Sukeno) and a leading global developer and manufacturer of human induced pluripotent stem (iPS) cell technologies,... Read more

June 6, 2018 Licensing, IP, and Legal M&A, Partnerships

Fujifilm Cellular Dynamics Announces Agreement with UCI to Commercialize iPSC-Derived Microglia and Media Formulation

Fujifilm Cellular Dynamics Announces Agreement with UCI to Commercialize iPSC-Derived Microglia and Media Formulation Usage of Cookies: Cookies are important to the proper functioning of this site. To improve your experience, we use cookies to remember log-in details and provide secure log-in, collect statistics to optimize site functionality and deliver content tailored to your interest.... Read more

December 22, 2017 Licensing, IP, and Legal

Cellular Dynamics International Sends Human iPSC-Derived Cardiomyocytes To International Space Station On NASA Resupply Mission

Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Astrocytes iCell Cardiac Progenitor Cells iCell Cardiomyocytes iCell Cardiomyocytes2 iCell DopaNeurons iCell Endothelial Cells iCell GABANeurons iCell GlutaNeurons iCell Hematopoietic Progenitor Cells iCell Hepatoblasts iCell Hepatocytes... Read more

September 20, 2017 Cell Analysis Tools M&A, Partnerships

Cellular Dynamics International Signs Agreement with Nanion Technologies to Enhance Mutual Offerings for Researchers

Madison, Wisconsin, September 20, 2017— Cellular Dynamics International (CDI), a FUJIFILM company , the leading developer and manufacturer of differentiated cells derived from human induced pluripotent stem cells (iPSCs), and Nanion Technologies GmbH (Nanion), a leading provider of instrumentation for ion channel drug discovery and screening, announced today that they have entered into a joint marketing agreement. The... Read more